Skip to main content
. 2016 Dec 20;34(2):495–512. doi: 10.1007/s12325-016-0464-9

Fig. 8.

Fig. 8

Adjusted Kaplan–Meier OS curves for dacarbazine and gp100 vs observed OS curve for GM-CSF, patients with early metastatic melanoma (stage IIIB–IV M1a). CI confidence interval, GM-CSF granulocyte-macrophage colony-stimulating factor, gp100 glycoprotein 100, OS overall survival